- Home
- GES vs NKTR Comparison
GES vs NKTR Comparison
Compare GES & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GES | NKTR |
|---|---|---|
| Founded | 1981 | 1990 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 872.4M | 807.8M |
| IPO Year | 1996 | 1994 |
Fundamental Metrics
Financial Performance| Metric | GES | NKTR |
|---|---|---|
| Price | $16.81 | $36.10 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | $16.75 | ★ $111.83 |
| AVG Volume (30 Days) | 380.8K | ★ 730.2K |
| Earning Date | 11-25-2025 | 03-11-2026 |
| Dividend Yield | ★ 5.34% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.07 | N/A |
| Revenue | ★ $3,144,417,000.00 | $62,600,000.00 |
| Revenue This Year | $8.97 | N/A |
| Revenue Next Year | $4.07 | N/A |
| P/E Ratio | $15.73 | ★ N/A |
| Revenue Growth | ★ 6.44 | N/A |
| 52 Week Low | $8.48 | $6.48 |
| 52 Week High | $17.15 | $66.92 |
Technical Indicators
Market Signals| Indicator | GES | NKTR |
|---|---|---|
| Relative Strength Index (RSI) | 46.96 | 34.41 |
| Support Level | $16.82 | $35.03 |
| Resistance Level | $16.88 | $38.29 |
| Average True Range (ATR) | 0.05 | 2.30 |
| MACD | 0.01 | 0.06 |
| Stochastic Oscillator | 37.50 | 18.73 |
Price Performance
Historical ComparisonAbout GES Guess? Inc.
Guess? Inc designs, markets distributes, and licenses contemporary apparel and accessories that reflect European fashion sensibilities and American Lifestyle under brands including Guess, Marciano, and G by Guess. The company has five reportable segments: Americas Retail, Americas Wholesale, Europe, Asia, and licensing. Geographically, the company derives maximum revenue from the United States.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.